Moderate Evidence Base: Certain oral dietary supplements have published research, though results vary across studies and individuals
Novo Nordisk conducted a randomized, double-blind, placebo-controlled phase 2b clinical trial called ELAD to evaluate the neuroprotective effects of liraglutide in patients with mild AD ( TABLE 1 Summary of the mechanisms of action and effects of GLP-1R agonists in AD
V.DonatoM
I do think theres probably more to it than just the weight loss. Hes used GLP-1 drugs in about two dozen lymphedema patients so far, calling the results very good. Dayan says hes not a paid consultant for Eli Lilly or Novo Nordisk, the pharmaceutical giants that make blockbuster GLP-1 drugs, and doesnt own any stock in the companies
The median onset times of GLP-1 RA-induced cholecystitis and cholelithiasis were statistically analyzed and compared
Health effects of dietary risks in 195 countries, 19902017: a systematic analysis for the Global Burden of Disease Study 2017